ZKTeco BioTime Vulnerability Allows Remote Cross-Site Scripting Attacks
CVE-2024-6523

5.4MEDIUM

Key Information:

Vendor

Zkteco

Status
Biotime
Vendor
CVE Published:
5 July 2024

Badges

👾 Exploit Exists🟡 Public PoC

What is CVE-2024-6523?

A vulnerability was found in ZKTeco BioTime up to 9.5.2. It has been classified as problematic. Affected is an unknown function of the component system-group-add Handler. The manipulation of the argument user with the input alert('XSS') leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. VDB-270366 is the identifier assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

BioTime 9.5.0

BioTime 9.5.1

BioTime 9.5.2

Exploit Proof of Concept (PoC)

PoC code is written by security researchers to demonstrate the vulnerability can be exploited. PoC code is also a key component for weaponization which could lead to ransomware.

CVE-2024-6523 - Proof of Concept

References

https://vuldb.com/?id.270366
vdb-entrytechnical-description
https://vuldb.com/?ctiid.270366
signaturepermissions-required
https://vuldb.com/?submit.364104
third-party-advisory

CVSS V3.1

Score:
5.4
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • 🟡

    Public PoC available

  • 👾

    Exploit known to exist

  • Vulnerability published

  • Vulnerability Reserved

Credit

Hussein Amer (VulDB User)
JSON
.